Lin Y, Berdeja J, Raje N, et al. First-in-human multicenter study of BB2121 anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma: updated results. EHA 2017, abstract 142.
ISTH 2020: over coagulatie in relatie tot COVID-19 en nog heel veel meer
aug 2020 | Benigne hematologie